Completed
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
NCT01744704
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
- Locations
-
- Covance Basel Research Unit AG - Lettenweg 118 - Allschwil, Switzerland
- COVANCE CLINICAL RESEARCH UNIT Ltd - Springfield House - Hyde Street Leeds, United Kingdom